Works by Nicolau, David P.

Results: 274

Comparison of the in vivo efficacy and resistance development potential between cefiderocol and ceftolozane/tazobactam human simulated exposures against Pseudomonas aeruginosa in 72-hour murine thigh infection model.

Published in:

Infectious Diseases, 2025, v. 57, n. 7, p. 658, doi. 10.1080/23744235.2025.2471822

By:

Fouad, Aliaa;
Nicolau, Samantha E.;
Tamma, Pranita D.;
Simner, Patricia J.;
Nicolau, David P.;
Gill, Christian M.

Publication type:

Article

Pharmacokinetics of ABT-773, a new semi-synthetic ketolide in neutropenic lung-infected mice: a population approach.

Published in:

Journal of Pharmacy & Pharmacology, 2002, v. 54, n. 1, p. 71, doi. 10.1211/0022357021771940

By:

Xuan, Dawei;
Ye, Min;
Kim, Myo;
Nightingale, Charles H.;
Nicolau, David P.

Publication type:

Article

Pharmacokinetics of Ticlopidine in the Rabbit.

Published in:

Journal of Pharmacy & Pharmacology, 1999, v. 51, n. 4, p. 393, doi. 10.1211/0022357991772583

By:

ONYEJI, CYPRIAN O.;
TESSIER, PAMELA R.;
NIGHTINGALE, CHARLES H.;
VALLEE, FRANCOIS;
NICOLAU, DAVID P.

Publication type:

Article

Directed carbapenemase testing is no longer just for Enterobacterales: cost, labor, and workflow assessment of expanding carbapenemase testing to carbapenem-resistant P. aeruginosa.

Published in:

Emerging Microbes & Infections, 2023, v. 12, n. 1, p. 1, doi. 10.1080/22221751.2023.2179344

By:

Gill, Christian M.;
Rajkotia, Poonam;
Roberts, Amity L.;
Tenover, Fred C.;
Nicolau, David P.

Publication type:

Article

Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge.

Published in:

Emerging Microbes & Infections, 2022, v. 11, n. 1, p. 811, doi. 10.1080/22221751.2022.2048972

By:

Tenover, Fred C.;
Nicolau, David P.;
Gill, Christian M.

Publication type:

Article

Pharmacokinetic and Pharmacodynaniic Properties of Meropenem.

Published in:

Clinical Infectious Diseases, 2008, v. 47, p. S32, doi. 10.1086/590064

By:

Nicolau, David P.

Publication type:

Article

Adherence to Highly Active Antiretroviral Therapy Predicts Virologic Outcome at an Inner-City Human Immunodeficiency Virus Clinic.

Published in:

Clinical Infectious Diseases, 2001, v. 33, n. 5, p. 1, doi. 10.1086/322590

By:

McNabb, JoCarol;
Ross, Jack W.;
Abriola, Kenneth;
Turley, Christina;
Nightingale, Charles H.;
Nicolau, David P.

Publication type:

Article

Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals.

Published in:

2011

By:

Eagye, Kathryn J;
Nicolau, David P

Publication type:

Journal Article

Tetracycline--Induced Pancreatitis.

Published in:

American Journal of Gastroenterology (Springer Nature), 1991, v. 86, n. 11, p. 1669

By:

Nicolau, David P.;
Mengedoht, Daniel E.;
Kline, Jeffrey J.

Publication type:

Article

The challenges of patient satisfaction: influencing factors and the patient - provider relationship in the United States.

Published in:

2017

By:

Baummer - Carr, Arlinda;
Nicolau, David P.

Publication type:

journal article

In vitro potency of amikacin against carbapenem-resistant Pseudomonas aeruginosa: A target for nebulization strategy?

Published in:

Brazilian Journal of Infectious Diseases, 2022, v. 26, n. 2, p. 1, doi. 10.1016/j.bjid.2022.102355

By:

Cuba, Gabriel T.;
Santos, Paulo H. D.;
Pignatari, Antonio C. C.;
Nicolau, David P.;
Kiffer, Carlos R. V.

Publication type:

Article

Assessing the pharmacodynamic profile of intravenous antibiotics against prevalent Gram-negative organisms collected in Colombia.

Published in:

Brazilian Journal of Infectious Diseases, 2011, v. 15, n. 5, p. 413, doi. 10.1016/S1413-8670(11)70221-5

By:

Villegas, Maria Virginia;
Briceno, David Felipe;
Ruiz, Sory Jamil;
Furtado, Guilherme H.;
Nicolau, David P.

Publication type:

Article

Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Novel Therapy for Multidrug Resistant Gram Negative Infections in Children.

Published in:

Current Pediatric Reviews, 2018, v. 14, n. 2, p. 97, doi. 10.2174/1573396314666180308150908

By:

Rodriguez, Brittany A.;
Girotto, Jennifer E.;
Nicolau, David P.

Publication type:

Article

Management of Pneumonia in the Pediatric Critical Care Unit: An Area for Antimicrobial Stewardship.

Published in:

Current Pediatric Reviews, 2017, v. 13, n. 1, p. 49, doi. 10.2174/1573396312666161205102221

By:

Dassner, Aimee M.;
Nicolau, David P.;
Girotto, Jennifer E.

Publication type:

Article

Pharmacokinetics of continuous infusion ceftolozane/tazobactam in two patients with extensive total body surface area burns.

Published in:

Pharmacotherapy, 2025, v. 45, n. 6, p. 386, doi. 10.1002/phar.70019

By:

Olivet, Jay D.;
Amerson‐Brown, Megan;
Calix, Juan J.;
Graffice, Emma;
Kilpatrick, Tyson;
Roenfanz, Hanna F.;
Nicolau, David P.;
Kuti, Joseph L.;
Brown, Matthew L.

Publication type:

Article

A guide to therapeutic drug monitoring of β‐lactam antibiotics.

Published in:

Pharmacotherapy, 2021, v. 41, n. 2, p. 220, doi. 10.1002/phar.2505

By:

Fratoni, Andrew J.;
Nicolau, David P.;
Kuti, Joseph L.

Publication type:

Article

Derivation of Meropenem Dosage in Patients Receiving Continuous Veno-Venous Hemofiltration Based on Pharmacodynamic Target Attainment.

Published in:

Chemotherapy (0009-3157), 2005, v. 51, n. 4, p. 211, doi. 10.1159/000086598

By:

Kuti, Joseph L.;
Nicolau, David P.

Publication type:

Article

Comparative Pharmacokinetic and Pharmacodynamic Profile of Piperacillin/Tazobactam 3.375G Q4H and 4.5G Q6H.

Published in:

Chemotherapy (0009-3157), 2002, v. 48, n. 2, p. 59, doi. 10.1159/000057663

By:

Mattoes, Holly M.;
Capitano, Blair;
Kim, Myo-Kyoung;
Xuan, Dawei;
Quintiliani, Richard;
Nightingale, Charles H.;
Nicolau, David P.

Publication type:

Article

Circulating Tumor Necrosis Factor-Alpha Production during the Progression of Rat Endotoxic Sepsis.

Published in:

Chemotherapy (0009-3157), 2001, v. 47, n. 3, p. 194, doi. 10.1159/000063221

By:

Xuan, Dawei;
Nicolau, David P.;
Nightingale, Charles H.;
Quintiliani, Richard

Publication type:

Article

Pharmacokinetics of High-Dose Meropenem in Adult Cystic Fibrosis Patients.

Published in:

Chemotherapy (0009-3157), 2001, v. 47, n. 3, p. 153, doi. 10.1159/000063216

By:

Bui, Khanh Q.;
Ambrose, Paul G.;
Nicolau, David P.;
Lapin, Craig D.;
Nightingale, Charles H.;
Quintiliani, Richard

Publication type:

Article

Comparison of the Bactericidal Activity of Trovafloxacin and Ciprofloxacin, Alone and in Combination with Cefepime, against Pseudomonas aeruginosa.

Published in:

Chemotherapy (0009-3157), 2000, v. 46, n. 6, p. 383, doi. 10.1159/000007318

By:

McNabb, JoCarol;
Quintiliani, Richard;
Nightingale, Charles H.;
Nicolau, David P.

Publication type:

Article

Pharmacodynamics of Intermittent- and Continuous-Infusion Cefepime Alone and in Combination with Once-Daily Tobramycin against Pseudomonas aeruginosa in an in vitro Infection Model.

Published in:

Chemotherapy (0009-3157), 1999, v. 45, n. 4, p. 284, doi. 10.1159/000007198

By:

Tessier, Pamela R.;
Nicolau, David P.;
Onyeji, Cyprian O.;
Nightingale, Charles H.

Publication type:

Article

Optimising Dosing Strategies of Antibacterials Utilising Pharmacodynamic Principles: Impact on the Development of Resistance.

Published in:

Drugs, 2006, v. 66, n. 1, p. 1, doi. 10.2165/00003495-200666010-00001

By:

DeRyke, C. Andrew;
Su Young Lee;
Kuti, Joseph L.;
Nicolau, David P.

Publication type:

Article

Antibacterial activity of ceftolozane/tazobactam alone and in combination with other antimicrobial agents against MDR Pseudomonas aeruginosa.

Published in:

2018

By:

Monogue, Marguerite L;
Nicolau, David P

Publication type:

journal article

Novel pharmacotherapy for the treatment of hospital-acquired and ventilator-associated pneumonia caused by resistant gram-negative bacteria.

Published in:

Expert Opinion on Pharmacotherapy, 2018, v. 19, n. 4, p. 397, doi. 10.1080/14656566.2018.1438408

By:

Kidd, James M.;
Kuti, Joseph L.;
Nicolau, David P.

Publication type:

Article

Non-KPC Attributes of Newer β-lactam/β-lactamase Inhibitors, Part 1: Enterobacterales and Pseudomonas aeruginosa.

Published in:

Clinical Infectious Diseases, 2024, v. 79, n. 1, p. 33, doi. 10.1093/cid/ciae048

By:

Fratoni, Andrew J;
Gethers, Matthew L;
Nicolau, David P;
Kuti, Joseph L

Publication type:

Article

Carbapenem-Resistant Enterobacterales, Carbapenem Resistant Organisms, Carbapenemase-Producing Enterobacterales, and Carbapenemase-Producing Organisms: Terminology Past its “Sell-By Date” in an Era of New Antibiotics and Regional Carbapenemase Epi...

Published in:

Clinical Infectious Diseases, 2020, v. 71, n. 7, p. 1776, doi. 10.1093/cid/ciaa122

By:

Livermore, David M.;
Nicolau, David P.;
Hopkins, Katie L.;
Meunier, Danièle

Publication type:

Article

Development of Daptomycin Susceptibility Breakpoints for Enterococcus faecium and Revision of the Breakpoints for Other Enterococcal Species by the Clinical and Laboratory Standards Institute.

Published in:

Clinical Infectious Diseases, 2020, v. 70, n. 6, p. 1240, doi. 10.1093/cid/ciz845

By:

Satlin, Michael J;
Nicolau, David P;
Humphries, Romney M;
Kuti, Joseph L;
Campeau, Shelley A;
II, James S Lewis;
Weinstein, Melvin P;
Jorgensen, James H

Publication type:

Article

Falsely elevated vancomycin-concentration values from enzyme immunoassay leading to treatment failure.

Published in:

American Journal of Health-System Pharmacy, 2020, v. 77, n. 1, p. 9, doi. 10.1093/ajhp/zxz258

By:

Singer, Bridger;
Stevens, Ryan W;
Westley, Benjamin P;
Nicolau, David P

Publication type:

Article

Use of continuous infusion ceftolozane–tazobactam with therapeutic drug monitoring in a patient with cystic fibrosis.

Published in:

American Journal of Health-System Pharmacy, 2019, v. 76, n. 8, p. 501, doi. 10.1093/ajhp/zxz011

By:

Davis, Sarah Elizabeth;
Ham, Jared;
Hucks, Jennifer;
Gould, Alyssa;
Foster, Rachel;
Justo, Julie Ann;
Nicolau, David P;
Bookstaver, P Brandon

Publication type:

Article

Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.

Published in:

American Journal of Health-System Pharmacy, 2018, v. 75, n. 14, p. 1048, doi. 10.2146/ajhp170839

By:

Asempa, Tomefa E.;
Avery, Lindsay M.;
Kidd, James M.;
Kuti, Joseph L.;
Nicolau, David P.

Publication type:

Article

Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.

Published in:

American Journal of Health-System Pharmacy, 2018, v. 75, n. 1, p. e36, doi. 10.2146/ajhp170123

By:

Monogue, Marguerite L.;
Abuhussain, Safa S. Almarzoky;
Kuti, Joseph L.;
Nicolau, David P.

Publication type:

Article

Physical compatibility of isavuconazonium sulfate with select i.v. drugs during simulated Y-site administration.

Published in:

American Journal of Health-System Pharmacy, 2017, v. 74, n. 1, p. e55, doi. 10.2146/ajhp150733

By:

Wonhee So;
Kim, Liz;
Thabit, Abrar K.;
Nicolau, David P.;
Kuti, Joseph L.

Publication type:

Article

Physical compatibility of ceftolozane-tazobactam with selected i.v. drugs during simulated Y-site administration.

Published in:

American Journal of Health-System Pharmacy, 2017, v. 74, n. 1, p. e47, doi. 10.2146/ajhp150762

By:

Thabit, Abrar K.;
Yukihiro Hamada;
Nicolau, David P.

Publication type:

Article

Physical compatibility of tedizolid phosphate with selected i.v. drugs during simulated Y-site administration.

Published in:

American Journal of Health-System Pharmacy, 2016, v. 73, n. 21, p. 1769, doi. 10.2146/ajhp150721

By:

Ghazi, Islam;
Yukihiro Hamada;
Nicolau, David P.

Publication type:

Article

Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and –20 °C.

Published in:

American Journal of Health-System Pharmacy, 2014, v. 71, n. 17, p. 1480, doi. 10.2146/ajhp130664

By:

JAIN, JAMI G.;
SUTHERLAND, CHRISTINA;
NICOLAU, DAVID P.;
KUTI, JOSEPH L.

Publication type:

Article

Impact of Order-Set Modifications and Provider Education Following Guideline Updates on Broad-Spectrum Antibiotic Use in Patients Admitted With Community Acquired Pneumonia.

Published in:

Hospital Pharmacy, 2022, v. 57, n. 4, p. 496, doi. 10.1177/00185787211055797

By:

Colmerauer, Jessica L.;
Linder, Kristin E.;
Dempsey, Casey J.;
Kuti, Joseph L.;
Nicolau, David P.;
Bilinskaya, Anastasia

Publication type:

Article

Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department.

Published in:

2018

By:

Nicolau, David P;
Kuti, Joseph L;
Almarzoky Abuhussain, Safa S;
Keyloun, Katelyn R;
Burak, Michelle A;
Nailor, Michael D;
Kohman, Kelsey N;
Jacknin, Gabrielle;
Tart, Serina B;
Hobbs, Athena L V;
Adams, Danyel K

Publication type:

journal article

Comparison of tigecycline penetration into the epithelial lining fluid of infected and uninfected murine lungs.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 4, p. 837, doi. 10.1093/jac/dkp301

By:

Crandon, Jared L.;
Kim, Aryun;
Nicolau, David P.

Publication type:

Article

Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 5, p. 982, doi. 10.1093/jac/dkp056

By:

Koomanachai, Pornpan;
Kim, Aryun;
Nicolau, David P.

Publication type:

Article

Pharmacokinetics of dalbavancin in plasma and skin blister fluid.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2007, v. 60, n. 3, p. 681, doi. 10.1093/jac/dkm263

By:

David P. Nicolau;
Heather K. Sun;
Elyse Seltzer;
Mary Buckwalter;
James A. Dowell

Publication type:

Article

The OPTAMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 5, p. 990, doi. 10.1093/jac/dki358

By:

Robert G. Masterton;
Joseph L. Kuti;
Philip J. Turner;
David P. Nicolau

Publication type:

Article

Efficacy of pulsatile amoxicillin and clarithromycin dosing alone and in combination in a murine pneumococcal pneumonia model.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 3, p. 559, doi. 10.1093/jac/dki261

By:

Heather K. Sun;
Su Young Lee;
Mary Anne Banevicius;
Xiaoli Du;
Dana Maglio;
David P. Nicolau

Publication type:

Article

Penetration, efflux and intracellular activity of tigecycline in human polymorphonuclear neutrophils (PMNs).

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 3, p. 498, doi. 10.1093/jac/dki260

By:

Christine T. Ong;
Chinedum P. Babalola;
Charles H. Nightingale;
David P. Nicolau

Publication type:

Article

Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 56, n. 2, p. 388, doi. 10.1093/jac/dki243

By:

Chonghua Li;
Joseph L. Kuti;
Charles H. Nightingale;
Debra L. Mansfield;
Adrian Dana;
David P. Nicolau

Publication type:

Article

The OPTAMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2005, v. 55, n. 1, p. 71, doi. 10.1093/jac/dkh511

By:

Robert G. Masterton;
Joseph L. Kuti;
Philip J. Turner;
David P. Nicolau

Publication type:

Article

Adjunctive efficacy of granulocyte colony-stimulating factor on treatment of Pseudomonas aeruginosa pneumonia in neutropenic and non-neutropenic hosts.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2004, v. 53, n. 6, p. 1098, doi. 10.1093/jac/dkh237

By:

Chinedum P. Babalola;
Charles H. Nightingale;
David P. Nicolau

Publication type:

Article

Pharmacodynamic study of β-lactams alone and in combination with β-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible β-lactamase.

Published in:

Journal of Antimicrobial Chemotherapy (JAC), 2004, v. 53, n. 2, p. 297

By:

Chonghua Li;
David P. Nicolau;
Philip D. Lister;
Richard Quintiliani;
Charles H. Nightingale

Publication type:

Article

Pharmacokinetic and pharmacodynamic profile of high dose extended interval piperacillin-tazobactam.

Published in:

2001

By:

Kim, Myo-Kyoung;
Xuan, Dawei;
Quintiliani, Richard;
Nightingale, Charles H.;
Nicolau, David P.;
Kim, M K;
Xuan, D;
Quintiliani, R;
Nightingale, C H;
Nicolau, D P

Publication type:

journal article

Modulation of efficacies and pharmacokinetics of antibiotics by granulocyte colony-stimulating factor in neutropenic mice with multidrug-resistant Enterococcus faecalis infection.

Published in:

2000

By:

Onyeji, Cyprian O.;
Nicolau, David P.;
Nightingale, Charles H.;
Bow, Laurine;
Onyeji, C O;
Nicolau, D P;
Nightingale, C H;
Bow, L

Publication type:

journal article